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ABSTRACT
An automated data analysis method for real-time
PCR needs to exhibit robustness to the factors
that routinely impact the measurement and analysis
of real-time PCR data. Robust analysis is paramount
to providing the same interpretation for results
regardless of the skill of the operator performing
or reviewing the work. We present a new method
for analysis of real-time PCR data, the maxRatio
method, which identifies a consistent point within
or very near the exponential region of the PCR
signal without requiring user intervention. Com-
pared to other analytical techniques that generate
only a cycle number, maxRatio generates several
measurements of amplification including cycle num-
bers and relative measures of amplification effi-
ciency and curve shape. By using these values, the
maxRatio method can make highly reliable reactive/
nonreactive determination along with quantitative
evaluation. Application of the maxRatio method to
the analysis of quantitative and qualitative real-time
PCR assays is shown along with examples of
method robustness to, and detection of, amplifica-
tion response anomalies.
INTRODUCTION
Real-time PCR has become a widely used methodology
for both qualitative and quantitative determination of
molecular targets. The power of real-time PCR is that
the ﬂuorescence response observed is a direct measure of
the dynamics of the ampliﬁcation reaction process. The
real-time PCR curve is a ﬂuorescence response with a
roughly sigmoidal shape that correlates to the growth of
ampliﬁed product during the PCR ampliﬁcation process.
The shape of the PCR ampliﬁcation curve reﬂects the
dynamics of the PCR reaction for an individual sample
that is controlled by the assay design, which includes reac-
tive components (primer and probe designs and concen-
trations, concentrations of enzymes, activators, buﬀers,
dNTPs, etc.) and cycling conditions for the reaction.
Current analytical methods primarily concentrate on
quantitative responses that involve cycle number determi-
nation. These approaches provide a quantitative assess-
ment by focusing on one portion of the ampliﬁcation
growth curve, namely the region of observed exponential
growth. The cycle threshold (Ct) method (1) determines a
cycle number based on the point where the ﬂuorescence
response grows above the background level to cross a
predetermined ﬂuorescence threshold value. The critical
steps involved in Ct determination include deﬁning the
baseline, establishing a suitable threshold for quantiﬁca-
tion of the target and using either an external calibration
curve or an internal quantitation standard (2) for quanti-
tation. The Ct method is an excellent method for provid-
ing quantitative PCR analysis because of the consistency
in signal intensity during the exponential growth phase of
the PCR. However, it is susceptible to baselining error
when challenged with signal anomalies such as spectral
crosstalk or transients due to bubbles in the reaction or
noise. For example, to generate a Ct value within the
exponential growth region of the PCR curve, a low thresh-
old may be required. With a low threshold, there is a
potential for a threshold crossing due to an anomalous
signal, e.g. spectral crosstalk rather than true ampliﬁca-
tion. It is diﬃcult to discriminate between a Ct value
caused by a false threshold crossing and one generated
by a valid reactive response. In such cases, analysis can
require some measure of interpretation on the part of the
data reviewer to assess whether a particular response is
truly an ampliﬁcation or not. In addition, it is diﬃcult
to determine the true Ct value in the presence of such
signal anomalies. Even small errors in the baselining pro-
cess can cause negative reactions to cross the threshold or
reactive signals to cross early or late. An alternate method
for determination of cycle numbers is the use of derivative
methods, such as the second derivative maximum method
(3), which do not require baselining. Both Ct and deriva-
tive methods provide a cycle number response for the PCR
reaction, but do not provide any means for assessing the
eﬃciency of the individual reaction or suitability of the
PCR curve for quantitative analysis.
We present here a new method for analysis of real-time
PCR data, the maxRatio method, which identiﬁes a
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of the PCR signal without requiring user intervention.
Compared to other analysis techniques that generate
only a cycle number, maxRatio generates several measure-
ments of ampliﬁcation including cycle numbers and rela-
tive measures of ampliﬁcation eﬃciency and curve shape.
By using these values, the maxRatio method can achieve
highly reliable reactive/nonreactive determination along
with quantitative evaluation.
MATERIALS AND METHODS
maxRatiomethod description
The maxRatio method takes a PCR ampliﬁcation signal
and calculates a ratio at each cycle using Equation (1).
Ration ¼
Signaln
Signaln 1
  1 1
where Signaln is the measured real-time PCR ﬂuorescence
response for the target of interest at cycle n. Because
Equation (1) has the signal in the numerator and denomi-
nator, the ratio is a self-normalizing, dimensionless
expression. The eﬀect of normalization by a nearly con-
stant reference signal divides out and either raw or nor-
malized ﬂuorescence may be used. This self normalizing
characteristic also provides the ratio transformation with
an inherent insensitivity to variability in signal intensity
such as might occur from well-to-well within an instru-
ment or between instruments.
The ratio calculation transforms the roughly sigmoidal
shaped ampliﬁcation curve to a ratio curve with a well-
deﬁned peak. Figure 1 illustrates this transformation. The
ratio curve exhibits several well-deﬁned features.
The maximum value of the ratio curve deﬁnes two
values. The magnitude of the ratio curve at the maximum
is deﬁned as the MR (maxRatio) value. The cycle number
at which the maximum occurs is deﬁned as the FCN value
or fractional cycle number. The ratio curve is based on a
cycle-by-cycle ratio of signal intensities, which diﬀers from
the ﬁrst or second derivative maximum methods (3) as the
derivative calculation is a diﬀerence measurement. The
FCN value generated by the maxRatio method is conse-
quently not the same value as the cycle number generated
by either derivative method. The ratio curve has a char-
acteristic width, measured as the half width at half max-
imum, referred to as the width parameter.
The ratio curve is a relative measure of the ﬂuorescence
signal growth throughout the PCR reaction. The early
cycle ratio curve near zero represents the baseline region
of the PCR curve and the late cycle region corresponds to
the plateau phase. The ascending part of the ratio curve
corresponds to the exponential growth phase; the descend-
ing part of the ratio curve is the transition from the expo-
nential to the plateau phase in the PCR curve.
Nonreactive responses have ratio curves that are nearly
ﬂat with an MR value near zero. A ratio threshold can
be established, which separates reactive versus nonreactive
responses based on MR values.
The signal value, Signaln, in the ratio Equation (1)
includes the PCR signal intensity and the inherent back-
ground ﬂuorescence level. As such, MR values are a rela-
tive measure of reaction eﬃciency. The magnitude of the
MR value even for a perfectly eﬃcient reaction is always
less than one because of the inherent level of background
ﬂuorescence incorporated in the ratio equation. By includ-
ing the background ﬂuorescence in the ratio equation, the
resulting ratio curve avoids the problem of division by
zero and is highly insensitive to even moderate baseline
slope variation. Diﬀerent probe designs and dye/quencher
combinations can exhibit diﬀerent levels of quenching. An
assay with higher background ﬂuorescence will typically
have lower MR values.
Many eﬀorts have been made to estimate absolute PCR
reaction eﬃciency from individual responses (4–7).
Although an absolute measurement of reaction eﬃciency
would be ideal, it has been reported that even nominal
variations in baseline determination can make calculation
of absolute ampliﬁcation eﬃciency from individual
responses unreliable. Calculating initial starting concen-
tration using such an absolute eﬃciency measure is diﬃ-
cult. In any case, all such methods rely on precise removal
of background ﬂuorescence level and slope, and generally
require curve ﬁtting functions to relatively few points.
It should be noted that the relative eﬃciency measure
MR value generated by the maxRatio method is not
used to directly estimate reaction eﬃciency or to calculate
initial sample concentration. Instead, MR is used to deter-
mine if a response is reactive or nonreactive and for reac-
tive responses if it is a normal ampliﬁcation for that assay.
It has been found that for some assays, low target
ampliﬁcation curves exhibit suppressed signal levels, for
example due to competition with nonspeciﬁc ampliﬁcation
products. As a result, the exponential growth portion of
the ampliﬁcation curve is reduced. This causes the ratio
peak and therefore the FCN value to shift slightly earlier.
The result is a slight overquantitation for low copy sam-
ples. At the same time, these suppressed signals exhibit
reduced MR responses. We can take advantage of this
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Figure 1. MR, FCN and width deﬁnition. (A) PCR response and ratio
curve for a positive reaction with deﬁnition of MR, FCN and width.
(B) PCR response and ratio curve for a negative reaction.
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values for these samples to create an adjusted FCN value
(FCNA) that uses the MR value to compensate for the
earlier FCN determination. The FCNA is deﬁned in
Equation (2).
FCNA ¼ FCN   Log2ðMRÞ 2
Use of FCNA may provide more linear quantitation to
the lowest detectable responses for some assays.
Ratiothreshold use
The ratio threshold is used to separate populations of
responses based on relative reaction eﬃciency (MR)
values. Setting of the ratio threshold is determined by
characterization of the assay and is determined primarily
by analysis of negatives. One method might be to deter-
mine the mean and SD of the MR values for negative
reactions and then set the ratio threshold to a level of
the mean plus some number of SDs (typically 5 to 10
SD). Other considerations when setting the ratio threshold
include the presence of spectral crosstalk in multiplex
assays and signal anomalies such as initial transients.
Although shown in Figure 1 as a straight line, the ratio
threshold can be set with diﬀerent levels at diﬀerent
cycles. The setting of the ratio threshold is determined
during assay development and typically does not need to
be changed even for diﬀerent instruments or reagent lots.
Unlike the threshold used for Ct analysis, the ratio thresh-
old is only used to determine reactivity of the response. It
has no eﬀect on the FCN value used for quantiﬁcation of
positive reactions.
More than one ratio threshold can be established. While
one ratio threshold can be set on the basis of separating
nonreactive from reactive responses, a second threshold
can be applied based on separating normal reactive
responses from abnormal reactive responses.
Use of response shifting
Because the ratio transformation is inherently self-
compensating for reaction signal intensity, it can be
applied to a reaction’s raw ﬂuorescence signal. When a
reference dye is available, the normalized ﬂuorescence
signal is typically analyzed. It should be noted that the
ﬂuorescence signal naturally has a background level of
unquenched ﬂuorescence. Because of the division in the
ratio transformation, it is necessary to maintain this back-
ground ﬂuorescence level to avoid division by zero. As an
alternative to utilizing the raw or normalized ﬂuorescence
response directly, the response may be shifted to ﬁxed
positive background ﬂuorescence level. The advantage of
this response shifting is to eliminate sensitivity to factors
that can change the level of background ﬂuorescence, such
as variability in probe manufacture or ﬂuorescence con-
tamination in the thermal cycler block. The disadvantage
of shifting the response is that it removes the inherent
insensitivity to signal intensity and can introduce some
instrument-to-instrument variability. For this reason, if
response shifting is implemented, using a shift value near
the natural level of background ﬂuorescence is recom-
mended. It should be noted that shifting will directly
aﬀect the magnitude of the MR value. Shifting to a low
value will increase both the MR value of positive reactions
as well as the mean and SD of the MR for negative reac-
tions. In terms of statistical separation of populations, this
rarely makes signiﬁcant diﬀerence. Shifting to a low level
can also reduce robustness to spectral crosstalk, initial
signal transients and other anomalies in the baseline por-
tion of the ampliﬁcation response. It is important there-
fore when developing the assay, to focus on statistical
separation of reactive from nonreactive populations by
MR, not on maximizing the MR value.
Method implementation
The maxRatio method has been implemented as part of
the Abbott m2000
TM system. The m2000 system consists
of two instruments: the Abbott m2000sp and the m2000rt.
The m2000sp automates the extraction, puriﬁcation and
preparation of DNA and RNA from patient samples. The
m2000rt real-time PCR instrument ampliﬁes and detects
real-time PCR assays. Because the m2000 system has an
eﬀective automatic baselining algorithm, baseline slope
correction (but not oﬀset) is applied. Although normal-
ization and baseline slope correction are not required by
the maxRatio method, a small improvement in perfor-
mance may be achieved using them. In addition, the
signal has a smoothing ﬁlter applied. It is a feature of
the maxRatio method that a much more aggressive noise
ﬁlter can be applied without signiﬁcantly aﬀecting the
cycle number compared to the Ct method. The m2000rt
instrument implements a fourth order, zero-phase noise
ﬁlter. In order to obtain 0.01 cycle resolution, a cubic
spline interpolation is applied to the ratio curve.
Example datasets
The PCR data used to illustrate attributes of the
maxRatio analysis method consist of actual and modiﬁed
data derived from Abbott RealTime PCR assays pro-
cessed on the m2000 system. Modiﬁed data is used as
noted to demonstrate the performance of diﬀerent algo-
rithms to anomolous responses that may occur periodi-
cally in the course of normal processing.
RESULTS AND DISCUSSION
Assayquantification using maxRatio
A comparison of quantiﬁcation using the maxRatio algo-
rithm was made using an Abbott RealTime HIV-1 linear-
ity panel (8). A dilution series of Armored HIV-1 RNA
ranging from 7.44 log10 copies/ml to 1.56 log10 copies/ml
(27.5 million copies/ml to 36 copies/ml) was analyzed.
Three runs were performed with four replicates per run
at each concentration. All 12 replicates were detected for
the highest seven dilutions, while 11 out of 12 replicates
were detected at 36 copies/ml. The maxRatio method was
implemented with response shifting set to 0.7. FCN and
FCNA cycle numbers were used for quantitation by the
maxRatio method.
Figure 2 illustrates HIV-1 normalized FAM (6-carboxy-
ﬂuorescein) ﬂuorescence for one of the runs processed
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FCN values generates the characteristic MR–FCN plot
for this data. The only negative response is from the
negative control, which is identiﬁed in the MR versus
FCN plot with an MR value near zero. Since there is no
signal growth in reactions without target, the ratio curve is
nearly equal to zero throughout the ampliﬁcation process.
The MR value of approximately zero easily distinguishes
the negative response from the reactive samples.
Comparable quantiﬁcation performance using either
Ct, FCN or FCNA values was observed as shown in
Figure 3. Ct values were generated using m2000rt soft-
ware. This system uses an automatic baselining algorithm,
which determines the optimum background regression
region on an individual responses basis.
Qualititative dataanalysis
An Abbott RealTime Chlamydia trachomatis/Neisseria
gonorrhoeae (CT/NG) assay (not available in the US)
was used to test 623 patient specimens collected with the
Abbott multi-Collect Specimen Collection Kit. The sam-
ples included male and female urine specimens, male
urethral swab specimens and female endocervical and
vaginal swab specimens. A total of 15 Abbott RealTime
CT/NG runs were performed using three m2000sp and
two m2000rt instruments. The maxRatio method was
implemented without response shifting. Figure 4 shows
the MR–FCN plots for a representative subset of the
data. As can be seen, negative sample MR values are
exceptionally low for C. trachomatis responses. Neisseria
gonorrhoeae negative sample MR values are slightly ele-
vated and have FCN values between 35 and 40 showing
the eﬀect of modest spectral crosstalk from the internal
control responses.
Detection ofsuppressed amplification
The MR value consistently identiﬁes eﬃcient from ineﬃ-
cient ampliﬁcations even in the presence of factors such as
baseline anomalies. As discussed earlier, multiple ratio
thresholds can be established to partition responses into
categories such as nonreactive, normally reactive and
abnormally reactive. Figure 5 demonstrates this approach
using a RealTime HIV-1 example. A single well (C1) from
this run had a suppressed ampliﬁcation. The signal in this
well starts rising above background as early as cycle 12,
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Figure 2. Analysis by maxRatio of RealTime HIV-1 assay ampliﬁcation
plots. HIV-1 RNA ranging from 7.44 log10 copies/ml to 1.56 log10
copies/ml were tested in replicates of four using the m2000sp and
m2000rt instruments. (A) Ampliﬁcation plots of the HIV-1 normalized
FAM ﬂuorescence versus cycle number. (B) Corresponding plots after
applying the ratio transformation. (C) Plot of MR versus FCN values
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Figure 3. Analysis by maxRatio of a RealTime HIV-1 linearity panel.
HIV-1 RNA ranging from 7.44 log10 copies/ml to 1.56 log10 copies/ml
were tested using the m2000sp and m2000rt instruments. (A) Observed
versus assigned concentration calculated using Ct values. (B) Observed
versus assigned concentration calculated using FCN values.
(C) Observed versus assigned concentration calculated using FCNA
values.
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tive samples on the plate. The response for well C1 rises
above the Ct threshold, but the accuracy of quantiﬁcation
would be in doubt. Final ﬂuorescence level cannot be used
to invalidate this well in that it is comparable to the ﬁnal
ﬂuorescence from the wells with low viral load samples.
Figure 5C shows the clear partitioning of this abnormal
response from both the nonreactive and normal reactive
responses using two ratio thresholds. This approach
allows the ability to diﬀerentiate and invalidate such sup-
pressed ampliﬁcations without requiring visual inspection
by the operator. The Kinetic Outlier Detection (KOD)
method presented by Bar et al. (9) presents an approach
to detecting anomalous ampliﬁcation using an absolute
eﬃciency estimate. While a very attractive approach, this
method shares the issues common to other methods which
attempt to determine absolute eﬃciency from individual
responses. In particular, sensitivity to the background sub-
traction process, diﬃculty of identifying the exponential
region and complexity of implementation.
Primer dimers and other sources of nonspeciﬁc ampliﬁ-
cation can have a deleterious eﬀect on assay signal.
Nonspeciﬁc products can compete for resources and
thereby interfere with speciﬁc ampliﬁcations. Alterna-
tively, with SYBR assays, nonspeciﬁc ampliﬁcation
products can be falsely interpreted as positive reactions.
Nonspeciﬁc reactions are usually ineﬃcient with corres-
pondingly low MR values. To the extent that nonspeciﬁc
products aﬀect the PCR response shape, then maxRatio
should provide tools with which to identify compromised
assay results. Both suppressed ampliﬁcation and false
positives can be handled using maxRatio analysis with
careful selection of parameters.
Internal controlevaluation
Real-time PCR assays commonly include an internal con-
trol. In Abbott RealTime assays, the internal control pro-
vides conﬁrmation of the successful processing of the
sample from sample preparation through ampliﬁcation.
For the Abbott RealTime HIV-1 assay, PCR ampliﬁcation
of the internal control (IC) is accomplished with a diﬀer-
ent set of primers than those used to amplify HIV-1. The
IC primers target a sequence of 136nt that is derived from
the hydroxypyruvate reductase (HPR) gene from the
pumpkin plant. The IC Probe is labeled with VIC dye.
Because the IC is noncompetitive with the target reaction,
the IC MR and cycle number values are expected to be
consistent across all reactions independent of target con-
centration. Standard Ct analysis can only evaluate the
internal control based on cycle number. The maxRatio
analysis method may be used to provide a 2D evaluation
of the internal control. When setting the ratio threshold
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reactive from nonreactive responses, but rather to distin-
guish normal reactive from unacceptable reactive
responses. Using this 2D analysis, one can potentially dis-
tinguish between concentration and inhibition-related
problems. Figure 6 illustrates this evaluation. The IC
data from the same assay run used for Figure 5 is
shown. As can be seen, the response from well C1 crosses
the threshold at a comparable point to other reactions, but
is signiﬁcantly suppressed. This is reﬂected in the lower
plot with a corresponding suppressed MR value. This
response would not be deemed invalid by inspecting
cycle number alone. Also present are several late rising
internal control responses whose MR values are normal,
but cycle numbers are delayed.
Robustnessto spectral crosstalk
The broad, overlapping ﬂuorescence spectra of dyes used
in multiplex assays presents a challenge to accurately
determine the contribution of each dye response to the
measured signal. Although dye calibration procedures
are in general very eﬀective, several issues limit the ability
to perfectly calibrate a system. These include variable read
temperatures for diﬀerent assays, diﬀerences in mastermix
components compared to the dye calibration solution,
quencher used and even the probe oligo sequence (10).
As an example of the robustness of the maxRatio
method to spectral crosstalk, the response from a single
well (C6) in the HIV-1 data set shown in Figure 2 was
modiﬁed by taking a fraction of the signal from the
FAM response and adding it to the VIC response. This
simulates the eﬀect of spectral crosstalk commonly
observed with multiplex assays. The FAM response in
this reaction represents a typical 6.68 log copies/ml
sample and the VIC response a typical internal control.
From –1.4% to 1.4% of the FAM response was added to
the VIC response in increments of 0.2%. Figure 7 shows
the eﬀect of spectral crosstalk on VIC Ct and FCN values.
From nominal, over the range of spectral crosstalk tested,
Ct values varied from –1.50 to 0.47. From nominal, FCN
values varied only from –0.07 to 0.09 cycles.
Detection ofCt validity
By using both maxRatio and Ct methods simultaneously,
an enhancement to analysis validity can be obtained. As
shown in Figure 3, FCN, FCNA and Ct values closely
correlate to log sample concentration. Because of this
close correlation, they can be used to detect and invalidate
responses with baselining errors. The cycle diﬀerence
between the FCN or FCNA value and the Ct value
tends to be nearly constant across the dynamic range for
any particular assay. This cycle diﬀerence (FCNA – CT)
can be monitored as a parameter to assess validity of the
cycle number determination.
An example of how this FCNA – CT cycle diﬀerence is
used to detect invalid responses is provided in Figure 8.
The ﬁgure shows an anomalous assay response from an
Abbott RealTime HCV (11) (not available in the US) run
on the m2000rt with a manually prepared PCR plate. The
response exhibits a discontinuity in the background region
that caused an errant Ct determination. The exact source
of the anomaly is unknown, but it is possibly due to a
bubble in the PCR well or a similar transient event. The
anomaly resulted in the baselining process tilting the
response up causing it to cross the threshold early. To
evaluate the impact of this tilt on the analysis, the
response ﬂuorescence data was manually corrected and
reanalyzed. It should be noted that this manual correction
is not part of the maxRatio analysis algorithm, but only
used here to illustrate the ability to detect incorrect base-
lining. The Ct value of the original response was 24.16 and
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value was 30.48 and the FCNA value was 35.39. The base-
line anomaly caused a 6.32 cycle Ct change with only a
0.05 cycle FCNA change. The cycle diﬀerence (FCNA –
Ct) was 11.18 cycles for the uncorrected response and 4.91
cycles for the corrected response. Figure 8C displays the
cycle diﬀerence for the 28 positive assay responses from
the same PCR run. As can be seen, well G1 is clearly an
outlier.
CONCLUSION
The maxRatio method for analysis of real-time PCR reac-
tions provides a measure of concentration (FCN or
FCNA) together with a relative measure of reaction eﬃ-
ciency (MR) that are not present in other commonly used
data analysis algorithms. These measures are consistently
determined even in the presence of systematic and nonsys-
tematic errors in ampliﬁcation signals that can cause
errors in interpretation for other methods. The relative
reaction eﬃciency measurement by MR values provides
an eﬀective and reliable method for reactive/nonreactive
determinations as well as discrimination of normal versus
inhibited responses. Quantitative evaluation using
maxRatio generated cycle numbers is comparable in
linearity and precision to analysis based on Ct values.
Although examples in this article utilize probes for signal
generation, the method has been successfully applied to
SYBR green assays as well and should work for any ampli-
ﬁcation signal that exhibits a roughly sigmoidal shape.
While maxRatio analysis can be used by itself to anal-
yze PCR reactions, it may also be used to complement
traditional Ct analysis. The maxRatio analysis technique
can be used to determine assay reactivity so that Ct anal-
ysis is only applied to reactive signals. In addition, the Ct
value can be compared to the maxRatio FCN or FCNA
value to determine cycle number validity.
In the clinical laboratory setting, the data analysis
method needs to be robust to common sources of variance
which include multiple lots of assay reagents, the variability
of a large instrument population and diﬀerences in oper-
ator skill and training. The robustness of the maxRatio
method, along with the validity metrics it generates, pro-
vides the objective analysis necessary for an automated
data analysis method for a clinical real-time PCR system.
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Figure 8. Baseline anomaly of a RealTime HCV assay response.
(A) Ampliﬁcation plots of the HCV normalized FAM ﬂuorescence
versus cycle number. Solid line is actual response of well G1. Dashed
line represents the same response with discontinuity removed.
(B) Corresponding plots after Savitsky–Golay smoothing and baselin-
ing. (C) Plot of FCNA – Ct cycle diﬀerence versus Ct value for the 28
positive responses in the same PCR run.
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